PRESS

ZARGIS MEDICAL RECEIVES FDA CLEARANCE:
Energy Display and Timing Annotation Added to Cardioscan



PRINCETON, N.J., September 14, 2004 - Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (NASDAQ: SPDE), announced today it has received U.S. Food and Drug Administration (FDA) clearance to include a graphical display of the median energy level, timing, and duration of suspected heart murmurs during specific segments of the diastolic and systolic intervals of heartbeats recorded through the Zargis Acoustic Cardioscan (CardioscanTM).


The new displays will better represent the distribution of acoustic energy of the heart for each recorded location and help physicians characterize suspected murmurs in terms of onset, duration and loudness. This clearance represents one of the planned development milestones required for a full commercial rollout of Cardioscan.


Zargis will be demonstrating Cardioscan, with energy display and timing annotation, at the American Heart Association Scientific Sessions in New Orleans on November 7th- 10th.


We have developed the most comprehensive and advanced heart sound analysis and interpretation algorithms in the world. This FDA clearance represents another first for Zargis and demonstrates our commitment to extending the clinical usefulness of cardiac auscultation (listening to heart sounds). Because auscultation is a difficult clinical skill, and with fewer than 28% of internal medicine programs in the United States offering any structured teaching in cardiac auscultation1, we see a need for continued innovations in the field of cardiac sound diagnostics, said John Kallassy, Managing Director of Zargis Medical.


The acoustic signal generated by the heart contains significant energy at frequencies below the threshold of human hearing. The decline in auscultation skills has also led to a possible over-reliance on costly echocardiography for the diagnosis of heart murmurs. Consequently, a large percentage of echocardiograph studies are performed on patients with innocent heart murmurs.

About Cardioscan


Cardioscan is the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease. Cardioscan is easy to use, non-invasive, portable, and takes just minutes to perform. Developed by biomedical scientists from Siemens and Zargis over the past seven years, Cardioscan implements voice-guided protocol and graphical user interface while maintaining an efficient physician workflow. The system provides a summary of findings in terms that are readily understood by physicians with more quantitative auscultatory information than is possible through listening alone. Thus, Cardioscan enhances auscultation which has been universally employed through a stethoscope for nearly two hundred years.

About Zargis Medical Corp.


Zargis Medical Corp. was formed in January 2001 when Siemens Corporate Research Inc., a subsidiary of Siemens AG (NYSE: SI), and Speedus Corp. (NASDAQ: SPDE) co-invested in Zargis to further develop and commercially market an advanced acoustic technology for detecting abnormalities identified through analysis of heart sounds. Based in Princeton, New Jersey, Zargis is developing advanced diagnostic decision support products and services for primary care physicians, cardiologists and other healthcare professionals.


For additional information on Speedus Corp. or Zargis Medical, contact John Kallassy, 718.567.4358, jkallassy@speedus.com, or visit their websites at www.speedus.com and www.zargis.com.


For additional information on Siemens Corporate Research, visit their website at www.scr.siemens.com.


   1Mangione S, Nieman LZ, Gracely E, Kaye D. The teaching and practice of cardiac auscultation during internal medicine and cardiology training. A nationwide survey. Ann Intern Med. 1993 Jul 1;119(1):47-54.


 


Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.


 

July 30, 2010
Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems

July 21, 2010
Zargis Awarded U.S. Army Contract

June 11, 2010
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc. Exclusive License Agreement Allows Zargis to Expand into Respiratory Sounds Market

June 10, 2010
Zargis Medical Receives Top Honors at Medical Design Excellence Awards

May 27, 2010
Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds

May 13, 2010
U.S. Army to Showcase Zargis' Technology at Telemedicine Conference

April 20, 2010
3M Littmann Model 3200/Zargis Cardioscan Honored for Stethoscope/Software Design Innovation

April 12, 2010
Zargis Cardioscan Wins 'Best of the Best' red dot design award

September 29, 2009
Zargis Awarded Follow-On U.S. Army Contract; Mandates Expansion of Two Previous Awards

February 23, 2010
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia

February 15, 2010
Edison Best New Product Awards Taps 3M and Zargis

January 8th, 2010
Zargis Cardioscan Cleared for Sale in Canada

December 14, 2009
Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com

December 1, 2009 - IN THE NEWS
Popular Science Magazine Innovation of the Year Issue

December 1, 2009 - IN THE NEWS
Popular Science Cardioscan Video

December 1, 2009 - IN THE NEWS
Scoping Out Stethoscopes (Contemporary Pediatrics Magazine)

November 24, 2009
Zargis Cardioscan(TM) Featured on The Early Show on CBS


November 18, 2009 - IN THE NEWS
Zargis Builds a Better Stethoscope

November 12, 2009
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann(R) Model 3200 Stethoscope with Cardioscan Software

October 21, 2009
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned

September 24, 2009
3M Global Business Manager Ingrid Blair Joins Zargis Board


September 25, 2009 - IN THE NEWS
TAMC Heart Device Approved, Deploys to Pacific Areas

September 17, 2009
Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army

August 25, 2009
Zargis Cardioscan Unveiled Through Global Marketing and Distribution Alliance With 3M Company

August 19, 2009
3M Introduces First Electronic Stethoscope with Bluetooth Wireless Capability

October 9, 2008
Zargis Receives Additional Contracts from U.S. Army

February 20, 2008
Physicians use Cardioscan to Evaluate Student Athletes during Sports Physicals

October 25, 2007
3M and Zargis Announce Global Marketing Alliance

April 18, 2007
Zargis' Cardioscan Receives Televised News Coverage

November 6, 2006
Zargis Awarded U.S. Army Contract

October 9, 2006
Study Shows Cardioscan Leads to 41% Reduction of Unnecessary and Costly Cardiac Referrals by Physicians

September 13, 2006
Study Results for Zargis Cardioscan to be Presented at American Academy of Pediatrics Conference

September 11, 2006
The Wall Street Journal Recognizes Zargis Medical With Technology Innovation Award

November 16, 2005
Panel Agrees Zargis Prototype Would Improve Referral Accuracy with Heart Murmurs

October 26, 2005
Zargis Medical Awarded Fundamental New Patent

June 30, 2005
Zargis Conducts Physician Study to Show Potential Benefits to Physicians, Insurance Companies and Patients

March 15, 2005
Zargis CTO to Speak at Medical Devices Conference

November 29, 2004
White Paper "Computer Aided Auscultation of the Heart, the Clinical Opportunity" Available at Zargis Website

November 12, 2004
Zargis Signs Exclusive Pact With Johns Hopkins University

November 5, 2004
Zargis Medical Announces the Results of a Clinical Study in Hypertrophic Cardiomyopathy (HCM)

September 14, 2004
Zargis Medical receives FDA clearance: Energy Display and Timing Annotation Added to Cardioscan

June 1, 2004
FDA Clears Zargis' Pioneering Medical Device: First Computer-Aided Device to Assist in the Detection of Heart Murmurs

April 6, 2004
Zargis Medical Updates on FDA Submission

January 12, 2004
Healthcare Veteran Joins Zargis Board

October 27, 2003
Siemens Medical Solutions Leader Joins Zargis Board

July 9, 2003
Zargis Awarded Core Patent for Acoustic Cardioscan

May 21, 2003
Zargis Medical Files with FDA for Approval of Zargis Acoustic Cardioscan System

July 15, 2002
Zargis Medical Tests New Technology, Developed at Siemens, to Improve Diagnosis of Heart Murmurs

February 20, 2002
Zargis Medical Appoints Siemens' Veteran Hejazi As President And Chief Executive Officer

March 26, 2001
Siemens' and SPEEDUS' Start-Up, Zargis Medical Corp., Announces Four Appointments to Medical Experts Board; Changes Name From Sound Diagnostics

January 16, 2001
Siemens and SPEEDUS Team Together in Start-Up to Develop Technology For Rapidly Detecting Valvular Heart Disease During Routine Patient Examinations